Intuitive Surgical (ISRG) Raises FY12 Sales, Procedure Growth Guidance
Tweet
Share
E-mailGet Alerts ISRG Hot Sheet
Price: $378.81 +1.16%
Financial Fact:
Research and development: 62.6M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 62.6M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
On its Q1 conference call, Intuitive Surgical (Nasdaq: ISRG) CEO Gary Guthart has said the company is target FY12 sales growth of 19-21 percent. The company had been target sales growth of 17-19 percent. Procedures are expected to be up 25-27 percent, versus prior guidance of 24-26 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
Create E-mail Alert Related Categories
Conference Calls, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
